摘要
AIM: To evaluate the effects of eicosapentaenoic acid (EPA) on regional arterial stiffness assessed by strain rate using tissue Doppler imaging. METHODS: Nineteen eligible patients were prospectively studied (mean age 62 ± 8 years, 68% men). Subjects with large vessel complications and/or diabetes mellitus were excluded. The strain rate of the ascending aorta was measured by tissue Doppler imaging as an index of regional arterial stiffness, and brachial-ankle pulse wave velocity (baPWV) was measured as an index of degree of systemic arteriosclerosis. These indices were compared before and after administration of EPA at 1800 mg/d for one year. RESULTS: The plasma concentration of EPA increased significantly after EPA administration (3.0% ± 1.1% to 8.5% ± 2.9%, P < 0.001). There were no significant changes in baPWV (1765 ± 335 cm/s to 1745 ± 374 cm/s), low-density lipoprotein cholesterol levels (114 ± 29 mg/dL to 108 ± 28 mg/dL), or systolic blood pressure (131 ± 16 mmHg to 130 ± 13 mmHg) before and after EPA administration. In contrast, the strain rate was significantly increased by administration of EPA (19.2 ± 5.6 s-1, 23.0 ± 6.6 s-1, P < 0.05). CONCLUSION: One year of administration of EPA resulted in an improvement in regional arterial stiffness which was independent of blood pressure or serum cholesterol levels.
AIM:To evaluate the effects of eicosapentaenoic acid(EPA) on regional arterial stiffness assessed by strain rate using tissue Doppler imaging.METHODS:Nineteen eligible patients were prospectively studied(mean age 62 ± 8 years,68% men).Subjects with large vessel complications and/or diabetes mellitus were excluded.The strain rate of the ascending aorta was measured by tissue Doppler imaging as an index of regional arterial stiffness,and brachialankle pulse wave velocity(baPWV) was measured as an index of degree of systemic arteriosclerosis.These indices were compared before and after administration of EPA at 1800 mg/d for one year.RESULTS:The plasma concentration of EPA increased significantly after EPA administration(3.0% ± 1.1% to 8.5% ± 2.9%,P < 0.001).There were no significant changes in baPWV(1765 ± 335 cm/s to 1745 ± 374 cm/s),low-density lipoprotein cholesterol levels(114 ± 29 mg/dL to 108 ± 28 mg/dL),or systolic blood pressure(131 ± 16 mmHg to 130 ± 13 mmHg) before and after EPA administration.In contrast,the strain rate was significantly increased by administration of EPA(19.2 ± 5.6 s-1,23.0 ± 6.6 s-1,P < 0.05).CONCLUSION:One year of administration of EPA resulted in an improvement in regional arterial stiffness which was independent of blood pressure or serum cholesterol levels.
